Immunai is an AI-powered biotechnology platform that maps the human immune system at high resolution to facilitate the discovery and development of new immune-related therapeutics. The platform integrates cutting-edge single-cell genomics, multiomic data, and advanced machine learning to support pharma companies and research institutions in target discovery, preclinical evaluation, and clinical trial optimization, leading to smarter decision-making and accelerated drug development.
Visit Immunai's official website for product details and getting started.